Study of the influence of erythropoietin treatment on hemoglobin Alc levels in diabetic patients with chronic renal failure on hemodialysis

Target haemoglobin in the treatment of anaemia of chronic renal failure by recombinant human erythropoietin

Hepcidin as a biomarker for iron status in chronic kidney disease

CD28 T-lymphocytes as a marker of chronic inflammation in hemodialysis patients showing poor response to erythropoietin therapy

Influence of recombinant human erythropoietin therapy on plasma level of insulin-like growth factor type 1 (IGF-1) in chronic hemodialysis patients.

Plasma hepcidin levels in hemodialysis patients relationship to iron homeostasis anemia therapy inflammation and parameters of dialysis efficiency

Circulating levels of chemerin in chronic kidney disease patients

Anaemia of chronic renal failure : New perspectives

Treatment of anaemia in patients on regularhaemodialysis : Different modalities

Study of vitamin E level in haemodialysis patients